2Arai T, Kobayashi A, Ohya A, et al. Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial ehemo- embolization[J]. Int J Clin Oncol,2014,19(5) .-871 879.
3Nishida Y, Fujii H, Hagihara A, et al. Tumor lysis syndrome after transarterial embolization for hepatocellular carcinoma I-J]. Nihon Shokakibyo Gakkai Zasshi,2013,110(3)1441-448.
4Elbarouni B, Elmanfud O, Yan KT, et al. Temporal trend of in- hospital major bleeding among patients with non ST-lelvation acute coronary syndromes[J]. Am Heart J,2010,160(60): 420-427.
5T, Kobayhi A, Ohya A, et aJ. Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial chemo-embolization.lnt J Clin Oncol,2014,19(5):871-9.
6Nishida Y, Fujii H, Hagihara A, et al.Tumor lysis syndrome after transarterial embolization for hepatocellular carcinoma. Nihon Shokakibyo Gakkai Zasshi. 2013,110(3):441-8.
